A5524512
Moxonidine , ≥98% , 75438-57-2
Synonym(s):
4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
CAS NO.：75438-57-2
Empirical Formula: C9H12ClN5O
Molecular Weight: 241.68
MDL number: MFCD06795643
EINECS: 629-833-3
| Pack Size | Price | Stock | Quantity |
| 50MG | RMB156.00 | In Stock |
|
| 200MG | RMB335.20 | In Stock |
|
| 250MG | RMB447.20 | In Stock |
|
| 1G | RMB1199.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 217-219° (dec) |
| Boiling point: | 364.7±52.0 °C(Predicted) |
| Density | 1.52±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Very slightly soluble in water, sparingly soluble in methanol, slightly soluble in methylene chloride, very slightly soluble in acetonitrile. |
| pka | 7.11±0.10(Predicted) |
| form | Solid |
| color | White to Almost white |
| Water Solubility | 800.3mg/L(temperature not stated) |
| Merck | 14,6293 |
| InChIKey | WPNJAUFVNXKLIM-UHFFFAOYSA-N |
Description and Uses
Moxonidine, which is structurally related to clonidine, is a new centrally acting antihypertensive that acts as a stronger agonist at imidazole receptors and a weaker agonist at α2-adrenergic receptors than clonidine. It is also reported to have less side effects and a much reduced potential to produce a rebound in blood pressure on withdrawal. Clinically, moxonidine appears to have comparable antihypertensive efficacy with the ACE inhibitors and calcium antagonists.
Antihypertensive;Imidazoline receptor agonist
Safety
| Symbol(GHS) |   GHS09,GHS06 |
| Signal word | Danger |
| Hazard statements | H411-H301 |
| Precautionary statements | P264-P270-P301+P310-P321-P330-P405-P501 |
| RIDADR | UN 2811 6.1/PG III |
| WGK Germany | 3 |
| RTECS | UV6260290 |
| HS Code | 2933.99.5300 |
| HazardClass | 6.1 |
| PackingGroup | III |
